WOOJUNG BIO Balance Sheet Health
Financial Health criteria checks 1/6
WOOJUNG BIO has a total shareholder equity of ₩21.9B and total debt of ₩50.7B, which brings its debt-to-equity ratio to 232.1%. Its total assets and total liabilities are ₩95.9B and ₩74.0B respectively.
Key information
232.1%
Debt to equity ratio
₩50.72b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩6.40b |
| Equity | ₩21.85b |
| Total liabilities | ₩74.02b |
| Total assets | ₩95.87b |
Financial Position Analysis
Short Term Liabilities: A215380's short term assets (₩18.3B) do not cover its short term liabilities (₩44.5B).
Long Term Liabilities: A215380's short term assets (₩18.3B) do not cover its long term liabilities (₩29.5B).
Debt to Equity History and Analysis
Debt Level: A215380's net debt to equity ratio (202.8%) is considered high.
Reducing Debt: A215380's debt to equity ratio has increased from 40.7% to 232.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A215380 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A215380 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.6% each year